A Kaiser score > 5 with breast MRI demonstrated a 97 percent sensitivity and 87.9 percent specificity for predicting malignancy in patients with BI-RADS 0 or 4 presentations on mammography and breast ultrasound, according to a new study.
|Articles|January 7, 2021
Hitachi, Olympus Sign Long-term Endoscopic Ultrasound System Alliance
Author(s)Whitney J. Palmer
Five-year contract furthers the companies’ existing partnership.
Advertisement
Hitachi and Olympus Corporation have inked a five-year deal that further solidifies their partnership in endoscopic ultrasound system development.
As part of this contract, announced Jan. 7, Hitachi will continue to supply diagnostic ultrasound systems and related parts to Olympus for use in the endoscopic ultrasound systems. The agreement will become valid after the pending transfer of Hitachi’s diagnostic imaging-related business to Fujifilm.
Related Content:
This deal marks the continuation of the Hitachi-Olympus endoscopic ultrasound system collaboration that began in the 1980s.
Advertisement
Related to this article
Catch up on the top radiology content of the past week.
For patients with hepatocellular carcinoma (HCC), perfusion beyond tumor margin on contrast-enhanced ultrasound that exceeds gray-scale ultrasound tumor measurement by 5 mm is associated with a 76 percent higher risk of worse recurrence-free survival, according to newly published research.
In the second of a three-part podcast episode, Wendie Berg, MD, PhD, FACR, FSBI, Manisha Bahl, MD, and Amy Patel, MD discuss how to handle disagreements with adjunctive AI in breast imaging, whether to include AI assessments in PACS, and whether patients should pay for the use of adjunctive AI.
Catch up on the top radiology content of the past week.
Magnetic resonance imaging offered a 29 percent higher sensitivity than CT for differentiating liver metastases, but CT provided 12 percent higher sensitivity than MRI for assessing vascular invasion, according to a new 40-study meta-analysis.
How will generative AI software be evaluated by the FDA in the future? What’s next for point-of-care ultrasound? What steps have been successful in facilitating adoption of AI applications across enterprise systems? Leaders in radiology and health care will be discussing these topics and more at the upcoming HLTH USA conference.
Newly published preclinical research signals a substantial conceptual shift with a potential role of photon-counting CT in targeting specific biological processes.
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
FDA Clears MRI-Based AI Software for Prognostic Evaluation of Patients with Mild Cognitive Impairment
2
FDA Clears AI-Enabled FFR-IQ Software for Estimating Fractional Flow Reserve from CCTA
3
The Reading Room Podcast: Emerging Concepts with AI Integration in Radiology
4
How AI, Theranostics and More Empowered Patients Have Led to Significant Changes in Radiology
5